Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,055 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trial.
Haidari G, Cope A, Miller A, Venables S, Yan C, Ridgers H, Reijonen K, Hannaman D, Spentzou A, Hayes P, Bouliotis G, Vogt A, Joseph S, Combadiere B, McCormack S, Shattock RJ. Haidari G, et al. Among authors: vogt a. Sci Rep. 2017 Oct 12;7(1):13011. doi: 10.1038/s41598-017-13331-1. Sci Rep. 2017. PMID: 29026141 Free PMC article. Clinical Trial.
Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.
Combadière B, Vogt A, Mahé B, Costagliola D, Hadam S, Bonduelle O, Sterry W, Staszewski S, Schaefer H, van der Werf S, Katlama C, Autran B, Blume-Peytavi U. Combadière B, et al. Among authors: vogt a. PLoS One. 2010 May 26;5(5):e10818. doi: 10.1371/journal.pone.0010818. PLoS One. 2010. PMID: 20520820 Free PMC article. Clinical Trial.
Hair follicle targeting, penetration enhancement and Langerhans cell activation make cyanoacrylate skin surface stripping a promising delivery technique for transcutaneous immunization with large molecules and particle-based vaccines.
Vogt A, Hadam S, Deckert I, Schmidt J, Stroux A, Afraz Z, Rancan F, Lademann J, Combadiere B, Blume-Peytavi U. Vogt A, et al. Exp Dermatol. 2015 Jan;24(1):73-5. doi: 10.1111/exd.12589. Epub 2014 Dec 8. Exp Dermatol. 2015. PMID: 25382068
Topically applied virus-like particles containing HIV-1 Pr55gag protein reach skin antigen-presenting cells after mild skin barrier disruption.
Rancan F, Afraz Z, Hadam S, Weiß L, Perrin H, Kliche A, Schrade P, Bachmann S, Schäfer-Korting M, Blume-Peytavi U, Wagner R, Combadière B, Vogt A. Rancan F, et al. Among authors: vogt a. J Control Release. 2017 Dec 28;268:296-304. doi: 10.1016/j.jconrel.2017.10.033. Epub 2017 Nov 5. J Control Release. 2017. PMID: 29080666
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination.
Gonçalves E, Bonduelle O, Soria A, Loulergue P, Rousseau A, Cachanado M, Bonnabau H, Thiebaut R, Tchitchek N, Behillil S, van der Werf S, Vogt A, Simon T, Launay O, Combadière B. Gonçalves E, et al. Among authors: vogt a. J Clin Invest. 2019 Mar 7;129(5):1960-1971. doi: 10.1172/JCI125372. Print 2019 May 1. J Clin Invest. 2019. PMID: 30843873 Free PMC article. Clinical Trial.
1,055 results